CB Therapeutics is applying innovative and proprietary biotechnology to cellular agriculture to make fermentation mankind’s most efficient and agile production process.
Yeast has been used since the earliest days of mankind to make bread, wine and beer. In the process of fermentation, yeast cells transform sugar into the natural molecules necessary for the production of many of our foods and beverages. We have selectively modified these organisms and created a production process to turn yeast into a robust biotechnology platform capable of producing an amazing range of molecules and compounds.
Many high value therapeutic compounds such as human growth hormone, insulin and blood clotting factors are already produced using genetically modified yeast. A number of phytochemicals that are extracted from plants and other molecules can be more efficiently produced, with less natural resources and environmental impact, utilizing yeast as a biochemical factory instead of extracting them from agricultural feedstock.
CB Therapeutics’ versatile bioproduction platform can leverage the fast growth rate of yeast on a variety of cheap feedstock for cost effective and quick product turnaround. Our biotech innovations enable our yeast to produce enzymes and compounds that would otherwise be detrimental to a cellular agriculture process. We are able to produce a wide range of bioidentical natural compounds with our platform. We are advancing the science of yeast and cellular agriculture to create the molecules, compounds and rare ingredients to make mankind healthier and happier and the world a better place to live. It all begins with an accomplished team, a small but incredible organism and some very big science.